Lilliefors test

From WikiMD's WELLNESSPEDIA


The Lilliefors test is a statistical test used to assess the goodness of fit of a distribution to a dataset. Specifically, it is an adaptation of the Kolmogorov-Smirnov test designed to test the null hypothesis that data come from a normally distributed population. Unlike the standard Kolmogorov-Smirnov test, which requires the mean and variance to be specified, the Lilliefors test is used when parameters such as the mean and variance are estimated from the data.

Background[edit]

The Lilliefors test was developed by Hubert Lilliefors, an American statistician, in 1967. The test is particularly useful because it adjusts the critical values for the effect of parameter estimation. When the parameters of the normal distribution (mean and variance) are estimated from the data, the critical values from the standard Kolmogorov-Smirnov test are no longer valid, as they assume known parameters. The Lilliefors test corrects for this by using simulation or other methods to generate the appropriate critical values.

Procedure[edit]

The Lilliefors test procedure involves several steps:

  1. Estimate the mean and variance from the sample data.
  2. Standardize the data using the estimated mean and variance.
  3. Compute the empirical cumulative distribution function (ECDF) of the standardized data.
  4. Calculate the maximum difference (D) between the ECDF and the cumulative distribution function (CDF) of the standard normal distribution.
  5. Compare the calculated D to a critical value from the Lilliefors distribution table. If D is greater than the critical value, the null hypothesis that the data are from a normal distribution is rejected.

Applications[edit]

The Lilliefors test is widely used in statistics to verify the assumption of normality, which is a common requirement in many parametric statistical tests and procedures. Ensuring that data are normally distributed can be crucial for the accurate application of tests such as the t-test, ANOVA, and many regression models.

Limitations[edit]

While the Lilliefors test is an effective tool for assessing normality, it has some limitations:

  • It is less powerful than other tests like the Shapiro-Wilk test for small sample sizes.
  • The test relies on tabulated values of critical points, which may not be available for all sample sizes and significance levels.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.